Eli Lilly | Omsætningsaktiver



Current Assets Lave om Dato
AbbVie USD 25.58B 2.2B 2024-12
Abbott USD 23.15B 503M 2025-03
ALKERMES USD 1.42B 167.74M 2024-12
Amgen USD 29.03B 2.26B 2024-12
AstraZeneca USD 26.14B 312M 2025-03
Baxter International USD 8.85B 11M 2024-12
Biogen USD 7.46B 626.3M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
Indivior 883M 44M 2025-03
J&J USD 71.55B 15.66B 2025-03
Medtronic USD 22.51B 75M 2025-01
Merck USD 38.78B 1.58B 2024-12
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Novo Nordisk 195.16B 17.66B 2024-09
Perrigo USD 2.48B 1.23B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Prestige Brands USD 377.16M 3.54M 2024-12
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
Sanofi 42.59B 12.51B 2024-12
United Therapeutics USD 3.94B 65.9M 2025-03
Zoetis USD 5.99B 296M 2024-12



Eli Lilly Omsætningsaktiver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.